Results 241 to 250 of about 381,559 (266)

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

New England Journal of Medicine, 2022
Neha Mehta-Shah, Hervé Tilly, Pau Abrisqueta   +2 more
exaly  

Improving Outcomes for Patients With Diffuse Large B-Cell Lymphoma

Ca-A Cancer Journal for Clinicians, 2010
Christopher Flowers, Rajni Sinha
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish Shanbhag, Richard Ambinder
exaly  

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter
exaly  

Chimeric antigen receptor T-cell therapies for lymphoma

Nature Reviews Clinical Oncology, 2017
James Kochenderfer, Jennifer Brudno, Brudno Jennifer N   +2 more
exaly  

Diffuse large B-cell lymphoma—treatment approaches in the molecular era

Nature Reviews Clinical Oncology, 2013
Louis Staudt, Mark Roschewski, Roschewski Mark   +2 more
exaly  

Promising new agent for B-cell lymphoma

Nature Reviews Clinical Oncology, 2010
Mandy Aujla, Aujla Mandy
exaly  

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

New England Journal of Medicine, 2019
Harald Holte, Ulrich Jäger, Joseph Mcguirk   +2 more
exaly  

Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

Nature, 2014
Jan Delabie, Andreas Rosenwald, Nagarajan Vaidehi   +2 more
exaly  

Immunotherapy in the B-cell lymphomas

Cytotherapy, 2002
openaire   +2 more sources